RecruitingNCT04521790
Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management
Studying Inherited arrhythmogenic cardiomyopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Scientific Institute San Raffaele
- Principal Investigator
- Paolo Della Bella, MDSan Raffaele Scientific Institute, Milan, Italy
- Intervention
- support treatment, cardiac medical treatment, aetiology-specific treatment, device implant, arrhythmia ablation(other)
- Enrollment
- 1000 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2018 – 2035
Study locations (1)
- IRCCS San Raffaele Scientific Institute, Milan, Milano, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04521790 on ClinicalTrials.govOther trials for Inherited arrhythmogenic cardiomyopathy
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06922994Statin Effect on Arrhythmogenic Cardiomyopathy Disease Progression (SEARCH)Centro Cardiologico Monzino
- RECRUITINGNCT06352307Risk Stratification, Early Prevention and Treatment Strategies for Arrhythmogenic CardiomyopathyFirst Affiliated Hospital Xi'an Jiaotong University
- RECRUITINGNCT06976606A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACMLexeo Therapeutics
- RECRUITINGPHASE1NCT05885412A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)Rocket Pharmaceuticals Inc.
- RECRUITINGNANCT06040242Arrhythmogenic Activity During Exercise in ARVC PatientsSwiss Federal Institute of Technology
- RECRUITINGNCT06409585Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis TransitionUniversity of Edinburgh
- RECRUITINGNANCT06311708Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)Tenaya Therapeutics
- RECRUITINGNCT06591260Role of Endomyocardial Biopsy and Aetiology-based Treatment in Pediatric Patients with Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management (MYOPED)Scientific Institute San Raffaele
See all trials for Inherited arrhythmogenic cardiomyopathy →